| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 01/25/2005 | US6846824 E.g., ethyl 3-(4-(2-(3-oxo-2H-1,4-benzoxazin-4-yl)ethoxy)-phenyl-2-ethoxypropenoate where 1,4-benzothiazine or quinoxaline can be substituted for the benzoxazine ring; anticholesterol, diabetic agents; obesity; hyperlimpidemia |
| 01/20/2005 | WO2005005400A1 Sulfonate compound and fluorescent probe using the same |
| 01/20/2005 | US20050014940 Process for the preparation of 2-or-9-oxa-3, 7-diazabicyclo (3.3.1) nonanes from 2-aminomethyl-2, 3-dihydrooxazines intermediates therefore, and processes for preparing such intermediates |
| 01/20/2005 | US20050014938 Phenyl substituted triazoles and their use as selective inhibitors of akl5 kinase |
| 01/20/2005 | US20050014746 compounds which bind to the interaction-domain (I-domain) of LFA-1, thus interrupting endothelial cell-leukocyte adhesion by blocking the interaction of LFA-1 with ICAM-1, ICAM-3, and other adhesion molecules |
| 01/19/2005 | EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2005 | EP1317511B1 Oxazine derivatives |
| 01/19/2005 | CN1568144A Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1185234C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
| 01/18/2005 | US6844446 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 01/18/2005 | US6844404 Catalyst compositions for the polymerization of olefins |
| 01/18/2005 | US6844003 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof |
| 01/13/2005 | US20050009930 Carotenoid analogs or derivatives for controlling connexin 43 expression |
| 01/13/2005 | US20050009871 Ubiquitin ligase inhibitors |
| 01/13/2005 | US20050009788 The analog includes a conjugated polyene with 7 to 14 double bonds and a 3,3-dimethylcyclohexenylene or 3,3-dimethylcyclohexen-6-onylene ring; especially for treating cardiac arrhythmia and cancerous and pre-cancerous cells |
| 01/13/2005 | US20050009758 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 01/11/2005 | US6841674 N-heterocyclic derivatives as NOS inhibitors |
| 01/11/2005 | US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 01/11/2005 | US6841550 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 01/06/2005 | WO2005000839A1 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | WO2005000406A2 Treatment of amyloid- and epileptogenesis-associated diseases |
| 01/06/2005 | WO2004087646A3 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases |
| 01/06/2005 | US20050004235 Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease |
| 01/06/2005 | US20050004112 C-fms kinase inhibitors |
| 01/06/2005 | US20050000791 Process for fractionating water-containing crude amine mixtures from amine synthesis |
| 01/06/2005 | CA2672071A1 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | CA2556706A1 Treatment of amyloid- and epileptogenesis-associated diseases |
| 01/06/2005 | CA2530377A1 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/05/2005 | EP1492774A2 Pyrimidone derivatives useful for the treatment of inflammation and immunological diseases |
| 01/05/2005 | EP1492757A1 (2-((2-alkoxy)-phenyl)-cyclopent-1-enyl) aromatic carbo- and heterocyclic carboxylic acid and derivatives |
| 01/05/2005 | EP1492537A1 Morpholine derivatives with a substituted acetamide group in the 2-position for use as ccr-3 antagonists for the treatment of inflammatory diseases |
| 01/05/2005 | EP1282414B1 Felbamate derived compounds for treating neuropathic pain |
| 01/05/2005 | CN1561348A Method for crosslinking hydrogels with morpholine-2, 3-diones |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/05/2005 | CN1183121C Method for preparing 2-(2-arylmorpholin-2-Y1) ethanol derivatives and intermediates |
| 12/30/2004 | US20040267011 Methods for synthesis of diarylmethanes |
| 12/29/2004 | WO2004113362A2 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions |
| 12/29/2004 | WO2004112688A2 7-alkyloxy-2h-1,4-benzoxacin-3(4h)-one derivatives and preparation method thereof |
| 12/29/2004 | EP1491537A1 Hydroxymorpholinone derivative and medicinal use thereof |
| 12/29/2004 | EP1490345A2 Novel compound |
| 12/29/2004 | EP1490324A2 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors |
| 12/29/2004 | EP1490043A2 Spirocyclic amides as cannabinoid receptor modulators |
| 12/29/2004 | EP0986545B1 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity |
| 12/29/2004 | EP0941092B1 Use of nk-1 receptor antagonists for treating major depressive disorders |
| 12/29/2004 | CN1182125C Process for synthesis of (2R,2-alpha-R,3a)-2-[1-(3,5-bis (trifluoromethyl) phenyl) ethoxy]-3-(4-fluophenyl)-1,4-oxazine |
| 12/29/2004 | CA2533480A1 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions |
| 12/23/2004 | WO2004111021A1 Cyclic hydroxylamine as psychoactive compounds |
| 12/23/2004 | WO2004110986A1 Benzamide derivative or salt thereof |
| 12/23/2004 | US20040259985 Ultraviolet radiation absorbents for thermoplastic polymers and methods of producing same |
| 12/23/2004 | US20040259891 Novel pyrimidon derivatives |
| 12/23/2004 | US20040259874 Morpholine dopamine agonists |
| 12/23/2004 | US20040259872 Crystal forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one |
| 12/23/2004 | US20040259871 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses |
| 12/23/2004 | DE10323701A1 Verfahren zur Synthese heterocyclischer Verbindungen Process for the synthesis of heterocyclic compounds |
| 12/23/2004 | CA2526387A1 Benzamide derivative or salt thereof |
| 12/23/2004 | CA2526209A1 Cyclic hydroxylamine as psychoactive compounds |
| 12/22/2004 | EP1489187A1 Osteoclast differentiation inhibitors |
| 12/22/2004 | EP1488792A2 Quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| 12/22/2004 | EP1487827A1 Anti-inflammatory morpholin-acetamide derivatives |
| 12/22/2004 | EP1487809A1 Process for the preparation of morpholine derivatives and intermediates therefore |
| 12/22/2004 | EP1487456A1 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions |
| 12/22/2004 | EP1487455A1 Morpholine derivatives substituted at the 2-position by an arylalkylurea group for use as ccr-3 antagonists in the treatment of inflammatory conditions |
| 12/22/2004 | EP1487454A1 Morpholine derivatives substituted at the 2-position by a heterocyclylalkylurea group for use as ccr-3 antagonists in the treatment of inflammatory conditions |
| 12/22/2004 | EP1487453A1 N- [(2s)-4-(3,4-difluorobenzyl)morpholin-2-yl]methyl -2- 3-[(methylsulphonyl)amino]phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions |
| 12/22/2004 | EP1133486B1 Nonsteroidal antiinflammatories |
| 12/22/2004 | EP1086076B1 Sulfonamide inhibitors of aspartyl protease |
| 12/22/2004 | EP1080066A4 Bioreductive cytotoxic agents |
| 12/16/2004 | US20040254249 Nonsteroidal antiinflammatory agents |
| 12/16/2004 | CA2527313A1 N-alkynyl-2-(substituted aryloxy) alkylthioamide derivatives as fungicides |
| 12/15/2004 | EP1486491A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient |
| 12/15/2004 | CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them |
| 12/14/2004 | US6831080 Cinnamide derivatives as KCNQ potassium channel modulators |
| 12/09/2004 | WO2004062586A3 Antineoplastic ether lipid compounds |
| 12/09/2004 | US20040248887 Selective in presence of at least one other cathepsin isozyme; such as N-{-2-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-cyclohexyl}-3-methyl-benzamide |
| 12/09/2004 | CA2527197A1 4-amino-2(5h)-furanones useful as cholecystokinin antagonists |
| 12/09/2004 | CA2525282A1 Indole derivatives with an improved antipsychotic activity |
| 12/08/2004 | EP1484301A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE |
| 12/08/2004 | EP1483228A1 Nk1 antagonists |
| 12/08/2004 | EP1482940A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 12/08/2004 | EP1482925A1 5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl!-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy |
| 12/08/2004 | CN1552699A Synthesis of benzoxazine monohydrochlorate compound |
| 12/08/2004 | CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 12/02/2004 | WO2004103976A2 Method for synthesising heterocyclic compounds from thiourea derivatives |
| 12/02/2004 | WO2004071389A3 Non-steroidal infalmmation inhibitors |
| 12/02/2004 | US20040242560 Process for synthesizing heterocyclic compounds |
| 12/02/2004 | US20040241563 Phenothiazine, phenoxazine, or phenazine derivatives; organophotoreceptor comprising electricoconductive substrate and photoconductive element; mechanical, electrostatic, and solubility properties; used with toners for quality images |
| 12/02/2004 | CA2526646A1 Method for synthesising heterocyclic compounds from thiourea derivatives |
| 12/01/2004 | EP1482376A1 Charge transport materials having heteroaromatic hydrazone groups |
| 12/01/2004 | EP1481970A1 Novel herbicides |
| 12/01/2004 | EP1481965A1 Aromatic amino acid derivatives and medicinal compositions |
| 12/01/2004 | EP1481012A1 Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerization |
| 12/01/2004 | EP1480628A1 Use of sodium/hydrogen exchange inhibitors for the treatment of thrombotic and inflammatory diseases |
| 12/01/2004 | EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds |
| 12/01/2004 | CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors |
| 12/01/2004 | CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
| 11/25/2004 | WO2004101536A1 Novel phenoxazinone derivatives as enzyme substrates and use thereof as indictor in the detection of microorganisms with peptidase activity |
| 11/25/2004 | WO2004083174A3 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors |
| 11/25/2004 | WO2004007407A3 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 11/25/2004 | US20040236103 amidation of an unsaturated carboxylic acid with an amino carboxylic acid; lactonization; decyclization to produce an alpha-hydroxy carboxylic acid; epoxidation; stereospecific synthesis; etomoxir, palmoxirate, or clomoxir; hypoglycemic agents; hyperlipemia |